Bethanne Cordova
Family · Excelsior Springs, MONPI 1750938320
Payments from drug & device makers
Across 343 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$530
- Lilly USA, LLC$481
- Otsuka America Pharmaceutical, Inc.$391
- Amgen$371
- Teva Pharmaceuticals USA, Inc.$361
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,920100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 91 | $1,450 |
| AstraZeneca | 32 | $530 |
| Lilly USA, LLC | 28 | $481 |
| Otsuka America Pharmaceutical, Inc. | 18 | $391 |
| Amgen | 22 | $371 |
| Teva Pharmaceuticals USA, Inc. | 22 | $361 |
| Novo Nordisk | 18 | $315 |
| Pfizer | 19 | $271 |
| Boehringer Ingelheim | 14 | $209 |
| GSK | 10 | $190 |
| Vanda Pharmaceuticals Inc. | 5 | $168 |
| Merck | 7 | $145 |
| Mylan Specialty L.p. | 8 | $124 |
| Astellas Pharma US Inc | 5 | $122 |
| Organon | 5 | $100 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $85 |
| Lundbeck LLC | 4 | $82 |
| Eisai Inc. | 4 | $79 |
| Bayer | 4 | $67 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| Nevro Corp. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $26 |
| Johnson & Johnson | 2 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Vertex | 1 | $18 |
| Biomerieux Inc | 1 | $17 |
| Biofire Diagnostics, LLC | 1 | $17 |
| Viatris Specialty LLC | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| Electromed, Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$5,924 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 46 | $36,632 |
| EliquisApixaban | 31 | $32,658 |
| OzempicSemaglutide | 31 | $30,121 |
| TrulicityDulaglutide | 18 | $25,477 |
| JardianceEmpagliflozin | 26 | $18,174 |
| FarxigaDapagliflozin Propanediol | 18 | $12,122 |
| MyrbetriqMirabegron | 14 | $11,572 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $7,408 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $4,871 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,326 |
| Omeprazole | 123 | $2,138 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 77 | $2,124 |
| Atorvastatin Calcium | 135 | $1,461 |
| Fluticasone Propionate | 54 | $1,373 |
| Gabapentin | 83 | $1,314 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $190 | $44,04061 claims |
| PfizerEliquis | $271 | $32,65831 claims |
| Novo NordiskOzempic | $315 | $30,12131 claims |
| Lilly USA, LLCTrulicity | $481 | $25,47718 claims |
| Boehringer IngelheimJardiance | $209 | $18,17426 claims |
| AstraZenecaFarxiga | $530 | $12,12218 claims |
| Astellas Pharma US IncMyrbetriq | $122 | $11,57214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.
Other family in Excelsior Springs
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.